Peplin Inc. (PEIC) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 27 PAGES: 30

More Info
									            Peplin Inc. (PEIC) - Financial and Strategic SWOT Analysis Review

       Reference Code: GDPH213341FSA                                                                                     Publication Date: MAY 2011

       6475 Christie Avenue, Suite 300 Phone                   +1 510 6539700                       Revenue           NA
       Emeryville, CA                  Fax                     +1 510 6539704                       Net Profit        -43.87 (million USD)
       94608                                 Website           www.peplin.com                       Employees         40
       United States                         Exchange          PEIC [Over The Counter]              Industry          Pharmaceuticals & Healthcare

      Company Overview
       Peplin Inc. (Peplin), formerly known as Peplin Biotech Ltd., is a development-stage, specialty pharmaceutical company. The
       company is engaged in research, advancing and commercialization of innovative medical dermatology product candidates. It
       focuses on developing PEP005 (ingenol mebutate), an anti-cancer drug, which is derived from Euphobia peplus, a plant referred
       to as radium weed or petty spurge, for indications such as actinic (solar) keratosis (AK) and basal cell carcinoma (BCC). PEP005
       Gel is useful as a topical, field-directed therapy for AK lesions on both head (face and scalp) and non-head (trunk and
       extremities) locations.

      Key Executives                                                                 SWOT Analysis
                     Name                                  Title                     Peplin Inc., SWOT Analysis
      Eugene Bauer, M.D.                    Chief Medical Officer                    Strengths                           Weaknesses

      Thomas G. Wiggans                     Chairman
                                                                                                                         Reliance on a Single Source
      Joshua Funder Ph.D.                   Director                                 Expertise In-house Research         Supplier
                                                                                     Activities
      Cherrell Hirst                        Director
                                                                                                                         Increasing Operating
      Gary W Pace, Ph.D.                    Director                                                                     Expenses
                                                                                     Intellectual Property Base
      Source: Annual Report, Company Website, Primary and Secondary Research,
      GlobalData

      Share Data
                                                                                     Opportunities                       Threats
       Peplin Inc.
                                                                            0.0      Leo Pharma’s Acquisition of         Uncertain R&D Outcomes
                                                                                     Peplin
       EPS (USD)                                                          -3.21
                                                                                                                         Increasing Competitive
       Market Cap (million USD)                                             0.0      Market Potential: Cancer            Pressures
       Enterprise Value (million USD)                                       NA

       Shares Outstanding (million)                                             15
       Source: Annual Report, Company Website, Primary and Secondary Research,       Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       GlobalData

      Financial Performance




       Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData




Peplin Inc. (PEIC) - Financial and Strategic SWOT Analysis Review                                                               Reference Code: GDPH213341FSA

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
      Table of Contents
      Table of Contents........................................................................................................................................................................................................... 2
      List of Tables .................................................................................................................................................................................................................. 3
      List of Figures................................................................................................................................................................................................................. 3
      Section 1 - About the Company ..................................................................................................................................................................................... 4
      Peplin Inc. - Key Facts ................................................................................................................................................................................................... 4
      Peplin Inc. - Key Employees .......................................................................................................................................................................................... 5
      Peplin Inc. - Key Employee Biographies ........................................................................................................................................................................ 6
      Peplin Inc. - Major Products and Services ..................................................................................................................................................................... 8
      Peplin Inc. - History ........................................................................................................................................................................................................ 9
      Peplin Inc. - Company Statement ................................................................................................................................................................................ 10
      Peplin Inc. - Locations And Subsidiaries...................................................................................................................................................................... 12
            Head Office............................................................................................................................................................................................................ 12
            Other Locations & Subsidiaries ............................................................................................................................................................................. 12
      Section 2 – Company Analysis .................................................................................................................................................................................... 13
      Peplin Inc. - Business Description................................................................................................................................................................................ 13
      Peplin Inc. - Corporate Strategy................................................................................................................................................................................... 14
      Peplin Inc. - SWOT Analysis ........................................................................................................................................................................................ 15
            SWOT Analysis - Overview ................................................................................................................................................................................... 15
            Peplin Inc. - Strengths ........................................................................................................................................................................................... 15
                  Strength - Expertise In-house Research Activities.......................................................................................................................................... 15
                  Strength - Intellectual Property Base .............................................................................................................................................................. 15
            Peplin Inc. - Weaknesses ...................................................................................................................................................................................... 15
                  Weakness - Reliance on a Single Source Supplier......................................................................................................................................... 15
                  Weakness - Increasing Operating Expenses .................................................................................................................................................. 15
                  Weakness - Deteriorating Profitability Ratios.................................................................................................................................................. 16
            Peplin Inc. - Opportunities ..................................................................................................................................................................................... 16
                  Opportunity - Leo Pharma’s Acquisition of Peplin........................................................................................................................................... 16
                  Opportunity - Market Potential: Cancer........................................................................................................................................................... 16
                  Opportunity - Changing Demographics........................................................................................................................................................... 16
            Peplin Inc. - Threats..............................................................................
								
To top